Le Lézard
Classified in: Health, Science and technology

Introducing HardyCHROM Burkholderia Cepacia Complex for USP <60>


SANTA MARIA, Calif., Oct. 29, 2020 /PRNewswire/ -- USP Chapter <60> describes tests to aid in detecting members of the Burkholderia cepacia complex group in non-sterile products. HardyChrom Bcc is highly selective for B. cepacia and 28 other Bcc strains, including B. cenocepacia and B. multivorans. HardyCHROM Bcc is inhibitory for P. aeruginosa. B. cepacia complex, comprised of 20 closely related species, are Gram negative, opportunistic bacteria that can grow in preserved aqueous oral/nasal liquids and topical products. This group of organisms is difficult to eliminate and capable of causing serious infections in patients with cystic fibrosis, those who are mechanically ventilated, or the immunosuppressed population with serious underlying disease.

HardyChrom Bcc provides vivid identification of Burkholderia cepacia. Growth of B. cepacia, or members of the Bcc group, are detected by a visible color change after three days of incubation at 30-35?, with formation of pink-to-magenta colonies.

Contact Hardy Diagnostics for more information. HardyChrom Bcc Cat. no. G335

Hardy Diagnostics was the first company to introduce chromogenic media to the United States in 1996. 

Hardy Diagnostics is an FDA licensed and ISO 13485 certified manufacturer of medical devices for microbiological procedures in both clinical and industrial laboratories. The company manufactures about 2,700 products for the culture and identification of bacteria and fungi from its Santa Maria, California headquarters and a second manufacturing facility in Ohio. Currently over 10,000 laboratories are serviced by Hardy Diagnostics throughout the nation. The company was founded in 1980 by Jay Hardy, a Clinical Laboratory Scientist from Santa Barbara, CA. Today, Hardy Diagnostics, a 100% employee owned company, maintains nine distribution centers throughout the U.S. and exports products to over 80 foreign distributors. The company's mission is to partner with its laboratory customers to prevent and diagnose disease.

Contact Person: Jay Hardy
Company Name: HARDY DIAGNOSTICS

Address: 1430 West McCoy Lane, Santa Maria, CA 93455
Phone Number: (800) 266-2222
Company Website: www.HardyDiagnostics.com

Related Images

hardychrom-burkholderia-cepacia.png
HardyCHROM Burkholderia Cepacia Complex for USP <60>
5-day growth example

Related Links

Hardy Diagnostics-Pharmaceutical Microbiology

 

SOURCE Hardy Diagnostics


These press releases may also interest you

at 08:15
RingCentral, Inc. , a leading provider of global enterprise cloud communications, collaboration, and contact center solutions, today announced that it has received the highest scores in every use case among 14 total vendors in the November 2020...

at 08:15
Luna Innovations Incorporated , a global leader in advanced optical technology, today announced it has acquired OptaSense Holdings, Ltd. ("OptaSense"), a QinetiQ company (LON: QQ), for 29 million British Pounds in cash. OptaSense is a recognized...

at 08:15
Benevity, Inc. ("Benevity"), a global leader in corporate purpose cloud software, today announces that it has secured an investment from Hg, a leading global software investor. Hg's investment is expected to further accelerate and scale Benevity's...

at 08:15
Vocera Communications, Inc. , a recognized leader in clinical communication and workflow solutions, today announced that Lake of the Woods District Hospital (LWDH) in Kenora, Ontario is deploying intelligent communication solutions from Vocera to...

at 08:15
With the holiday shopping season in high gear and COVID-19 cases continuing to skyrocket, identity theft and fraud is occurring at a record pace. According to the FBI, reported cybercrimes alone have risen 300% since the beginning of the pandemic....

at 08:15
Veritone, Inc. , a leading provider of artificial intelligence (AI) technology and solutions, today announced that it has priced its previously announced underwritten public offering consisting of 3,000,000 shares of its common stock, at a public...



News published on 29 october 2020 at 03:00 and distributed by: